CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

CAMP4 Therapeutics (Nasdaq:CAMP) granted a non-qualified stock option to purchase 5,000 shares of common stock to a new employee as an inducement award under Nasdaq Listing Rule 5635(c)(4).

Rhea-AI Summary

CAMP4 Therapeutics (Nasdaq:CAMP) granted a non-qualified stock option to purchase 5,000 shares of common stock to a new employee as an inducement award under Nasdaq Listing Rule 5635(c)(4).

The option has a 10-year term, an exercise price of $4.31, and vests over four years.

Argus May 22 session

+2.50% close to close 1.0x rel. volume Open Argus

Details

News Market Reaction – CAMP

On May 22, the first trading day after this news, CAMP closed 2.50% above the previous close.

Data tracked by StockTitan Argus for the May 22 session.

Key Figures

Inducement option size: 5,000 shares Exercise price: $4.31 per share Option term: 10 years +5 more

Inducement option size

5,000 shares

Non-qualified stock option grant to newly hired employee on May 15, 2026

Exercise price

$4.31 per share

Equal to CAMP4 common stock closing price on Grant Date

Option term

10 years

Term of inducement stock option grant

Vesting cliff

25% at 1 year

First tranche vesting on one-year employment anniversary

Remaining vesting schedule

36 monthly installments

Balance vests monthly over following three years

Vesting period

4 years

Total vesting period for inducement option award

Shelf registration capacity

$300,000,000

Maximum aggregate offering under Form S-3 shelf

ATM program size

$100,000,000

At-the-market prospectus supplement under shelf

Historical Context

5 past events · Latest: May 14

5 events

1. May 14

   Preclinical data update

   24h Move

   -2.7%

   New CMP-002 seizure-model data with statistically significant efficacy signals.

2. May 7

   Quarterly earnings

   24h Move

   +2.8%

   Q1 2026 results, EMA Orphan Designation, and cash runway into 2028.

3. Apr 28

   Scientific preprint

   24h Move

   -3.8%

   Preprint on regulatory RNA profiling and discovery of ASOs including CMP-002.

4. Apr 17

   Inducement option grants

   24h Move

   +0.5%

   Inducement stock options totaling 43,000 shares for three new hires.

5. Mar 24

   Board appointment

   24h Move

   -3.4%

   Appointment of experienced biotech CFO Michael MacLean to the board.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

non-qualified stock option, nasdaq listing rule 5635(c)(4), exercise price, inducement grant

4 terms

non-qualified stock option financial

"granted a non-qualified stock option to purchase 5,000 shares of the Company’s common stock"

A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.

nasdaq listing rule 5635(c)(4) regulatory

"as an inducement material to such employee’s entry into employment with the Company, in accordance with Nasdaq Listing Rule 5635(c)(4)"

NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.

exercise price financial

"an exercise price per share of $4.31, which is equal to the closing price"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

inducement grant financial

"in accordance with Nasdaq Listing Rule 5635(c)(4) (the “Inducement Grant”)"

An inducement grant is a stock-based reward given to a new hire—often options or restricted shares—used as a recruiting “signing bonus” to encourage someone to join a company and stay long enough to add value. Investors care because these grants can dilute existing shareholdings, change executive incentives and increase reported compensation costs, so they signal both management priorities and potential impacts on shareholder value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CAMBRIDGE, Mass., May 21, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels to treat a broad range of genetic diseases, today announced that on May 15, 2026 (the “Grant Date”), the Compensation Committee of the Company’s Board of Directors granted a non-qualified stock option to purchase 5,000 shares of the Company’s common stock to a newly hired employee of the Company as an inducement material to such employee’s entry into employment with the Company, in accordance with Nasdaq Listing Rule 5635(c)(4) (the “Inducement Grant”).

The Inducement Grant has a ten-year term and an exercise price per share of $4.31, which is equal to the closing price of CAMP4’s common stock as of the Grant Date. The Inducement Grant will vest over a four-year period, with 25% of the shares vesting on the one-year anniversary of the employee’s first day of employment with the Company, and thereafter the remainder of the option will vest in 36 equal monthly installments, subject to the employee’s continued service with CAMP4 through the applicable vesting dates. The Inducement Grant was granted pursuant to, and is subject to, the terms and conditions of an Inducement Option Award Agreement.

About CAMP4 Therapeutics 
CAMP4 is developing disease-modifying treatments for a broad range of genetic diseases where amplifying healthy protein may offer therapeutic benefits. Our approach amplifies mRNA by harnessing a fundamental mechanism of how genes are controlled. To amplify mRNA, our therapeutic ASO drug candidates target regulatory RNAs (regRNAs), which act locally on transcription factors and are the master regulators of gene expression. CAMP4’s proprietary RAP Platform® enables the mapping of regRNAs and generation of therapeutic candidates designed to target the regRNAs associated with genes underlying haploinsufficient and recessive partial loss-of-function disorders, of which there are more than 1,200, in which a modest increase in protein expression may have the potential to be clinically meaningful. For more information, visit camp4tx.com.

Contacts

Investor Relations:
Sara Michelmore
Milestone Advisors
sara@milestone-advisorsllc.com

Media:
Sofia Bermudez
LifeSci Communications
sbermudez@lifescicomms.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What inducement stock option did CAMP4 Therapeutics (CAMP) grant on May 15, 2026?

CAMP4 Therapeutics granted a non-qualified option for 5,000 CAMP shares as an inducement grant. According to the company, it was approved on May 15, 2026 and is tied to a newly hired employee’s employment.

What is the exercise price and term of the new CAMP4 Therapeutics (CAMP) inducement option grant?

The inducement stock option has a $4.31 exercise price and a 10-year term. According to CAMP4 Therapeutics, the price equals the closing share price on the May 15, 2026 grant date.

How does the CAMP4 Therapeutics (CAMP) inducement grant vest for the new employee?

The inducement option vests over four years with time-based milestones. According to CAMP4 Therapeutics, 25% vests on the one-year employment anniversary, then the remaining 75% vests in 36 equal monthly installments.

Why was the CAMP4 Therapeutics (CAMP) stock option classified as an inducement grant?

The stock option qualifies as an inducement grant because it is material to the new employee’s hiring. According to CAMP4 Therapeutics, it was issued in accordance with Nasdaq Listing Rule 5635(c)(4).

Does the CAMP4 Therapeutics (CAMP) inducement option depend on continued employment?

Yes, vesting of the inducement option depends on continued service with CAMP4 Therapeutics. According to the company, all vesting installments require the employee to remain in service through the applicable vesting dates.

How many CAMP4 Therapeutics (CAMP) shares are covered by the 2026 inducement option grant?

The 2026 inducement option covers 5,000 shares of CAMP4 Therapeutics common stock. According to the company, this non-qualified option was granted to a single newly hired employee under an Inducement Option Award Agreement.